arcane
发表于 2025-3-23 11:22:59
978-4-431-68221-9Springer-Verlag Tokyo 1992
鄙视读作
发表于 2025-3-23 15:45:31
http://image.papertrans.cn/n/image/664842.jpg
出来
发表于 2025-3-23 18:56:30
https://doi.org/10.1007/978-4-431-68219-6Angiotensin II; angina pectoris; arrhythmia; cardiovascular; cardiovascular system; drugs; heart; heart dis
切割
发表于 2025-3-24 01:41:40
Hisakazu Yasuda (Emeritus Professor),Hideaki Kawag
灾祸
发表于 2025-3-24 05:13:08
http://reply.papertrans.cn/67/6649/664842/664842_15.png
Irritate
发表于 2025-3-24 10:19:28
erage run length concept that can be used to quantify what a particular process-monitoring scheme can be expected to provide in Sect. 3.5. Finally, in Sect. 3.6 the chapter closes with a discussion clarifying the relationship between “statistical process control” and “engineering control” and presen
VOC
发表于 2025-3-24 11:13:57
http://reply.papertrans.cn/67/6649/664842/664842_17.png
atopic-rhinitis
发表于 2025-3-24 18:23:45
http://reply.papertrans.cn/67/6649/664842/664842_18.png
nonsensical
发表于 2025-3-24 22:02:43
http://reply.papertrans.cn/67/6649/664842/664842_19.png
蒙太奇
发表于 2025-3-25 01:22:09
Kazuo Ichiharafrom such scales, even though the scales themselves are quite reliable, precise, and sensitive to change. Without meaningful approaches to defining clinical significance, such scales are unlikely to become acceptable in clinical trials except, perhaps, as exploratory endpoints. This paper discusses